GERN vs. ABBV
Compare and contrast key facts about Geron Corporation (GERN) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GERN or ABBV.
Correlation
The correlation between GERN and ABBV is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GERN vs. ABBV - Performance Comparison
Key characteristics
GERN:
0.70
ABBV:
0.72
GERN:
2.59
ABBV:
1.02
GERN:
1.30
ABBV:
1.16
GERN:
0.80
ABBV:
0.90
GERN:
5.34
ABBV:
2.34
GERN:
14.54%
ABBV:
7.29%
GERN:
110.27%
ABBV:
23.65%
GERN:
-98.65%
ABBV:
-45.09%
GERN:
-94.59%
ABBV:
-11.11%
Fundamentals
GERN:
$2.14B
ABBV:
$314.02B
GERN:
-$0.32
ABBV:
$2.88
GERN:
-2.38
ABBV:
0.42
GERN:
$29.46M
ABBV:
$41.23B
GERN:
$28.67M
ABBV:
$30.76B
GERN:
-$138.52M
ABBV:
$17.62B
Returns By Period
In the year-to-date period, GERN achieves a 0.85% return, which is significantly lower than ABBV's 1.98% return. Over the past 10 years, GERN has underperformed ABBV with an annualized return of 1.36%, while ABBV has yielded a comparatively higher 15.63% annualized return.
GERN
0.85%
-10.75%
-21.19%
70.81%
22.43%
1.36%
ABBV
1.98%
2.70%
10.23%
16.35%
20.45%
15.63%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GERN vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Geron Corporation (GERN) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GERN vs. ABBV - Dividend Comparison
GERN has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.42%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GERN Geron Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ABBV AbbVie Inc. | 3.42% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
GERN vs. ABBV - Drawdown Comparison
The maximum GERN drawdown since its inception was -98.65%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for GERN and ABBV. For additional features, visit the drawdowns tool.
Volatility
GERN vs. ABBV - Volatility Comparison
Geron Corporation (GERN) has a higher volatility of 10.75% compared to AbbVie Inc. (ABBV) at 5.68%. This indicates that GERN's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GERN vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Geron Corporation and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities